（旧版）高血圧治療ガイドライン2009

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)//出典: J Hypertens/ 25巻, 6号, 1105-87頁/ 発行年 2007年

著者： Mancia G/De Backer G/Dominiczak A/Cifkova R/Fagard R/Germano G/Grassi G/Heagerty AM/Kjeldsen SE/Laurent S/Narkiewicz K/Ruilope L/Rynkiewicz A/Schmieder RE/Boudier HA/Zanchetti A/Vahanian A/Camm J/De Caterina R/Dean V/Dickstein K/Filippatos G/Funck-Brentano C/Hellemans I/Kristensen SD/McGregor K/Sechtem U/Silber S/Tendera M/Widimsky P/Zamorano JL/Erdine S/Kiowski W/Agabiti-Rosei E/Ambrosioni E/Lindholm LH/Viigimaa M/Adamopoulos S/Agabiti-Rosei E/Ambrosioni E/Bertomeu V/Clement D/Erdine S/Farsang C/Gaita D/Lip G/Mallion JM/Manolis AJ/Nilsson PM/O'Brien E/Ponikowski P/Redon J/Ruschitzka F/Tamargo J/van Zwieten P/Waeber B/Williams B/Management of Arterial Hypertension of the European Society of Hypertension/European Society of Cardiology

発行年： 2007

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group//出典: Lancet/ 351巻, 9118号, 1755-62頁/ 発行年 1998年

著者： Hansson L/Zanchetti A/Carruthers SG/Dahlöf B/Elmfeldt D/Julius S/Ménard J/Rahn KH/Wedel H/Westerling S

発行年： 1998

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised,double-blind,placebo-controlled,multicentre trial (the EUROPA study)//出典: Lancet/ 362巻, 9386号, 782-8頁/ 発行年 2003年

著者： Fox KM/EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators

発行年： 2003

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial//出典: J Hypertens/ 23巻, 3号, 641-8頁/ 発行年 2005年

著者： Lubsen J/Wagener G/Kirwan BA/de Brouwer S/Poole-Wilson PA/ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators

発行年： 2005

Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised,open-label,blinded endpoint morbidity-mortality study//出典: Lancet/ 369巻, 9571号, 1431-9頁/ 発行年 2007年

著者： Mochizuki S/Dahlöf B/Shimizu M/Ikewaki K/Yoshikawa M/Taniguchi I/Ohta M/Yamada T/Ogawa K/Kanae K/Kawai M/Seki S/Okazaki F/Taniguchi M/Yoshida S/Tajima N/Jikei Heart Study group

発行年： 2007

Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: candesartan antihypertensive survival evaluation in Japan trial//出典: Hypertension/ 51巻, 2号, 393-8. Epub 2008 Jan 2頁/ 発行年 2008年

著者： Ogihara T/Nakao K/Fukui T/Fukiyama K/Ueshima K/Oba K/Sato T/Saruta T/Candesartan Antihypertensive Survival Evaluation in Japan Trial Group

発行年： 2008

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators//出典: N Engl J Med/ 341巻, 10号, 709-17頁/ 発行年 1999年

著者： Pitt B/Zannad F/Remme WJ/Cody R/Castaigne A/Perez A/Palensky J/Wittes J

発行年： 1999

Eplerenone,a selective aldosterone blocker,in patients with left ventricular dysfunction after myocardial infarction//出典: N Engl J Med/ 348巻, 14号, 1309-21. Epub 2003 Mar 31頁/ 発行年 2003年

著者： Pitt B/Remme W/Zannad F/Neaton J/Martinez F/Roniker B/Bittman R/Hurley S/Kleiman J/Gatlin M/Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study Investigators

発行年： 2003

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)//出典: JAMA/ 288巻, 23号, 2981-97頁/ 発行年 2002年

著者： ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

発行年： 2002

Effects of an angiotensin-converting-enzyme inhibitor,ramipril,on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators//出典: N Engl J Med/ 342巻, 3号, 145-53頁/ 発行年 2000年

著者： Yusuf S/Sleight P/Pogue J/Bosch J/Davies R/Dagenais G

発行年： 2000

Cardiovascular protection and blood pressure reduction: a meta-analysis//出典: Lancet/ 358巻, 9290号, 1305-15頁/ 発行年 2001年

著者： Staessen JA/Wang JG/Thijs L

発行年： 2001

An overview of the meta-analyses of the hypertension treatment trials//出典: Arch Intern Med/ 151巻, 7号, 1277-9頁/ 発行年 1991年

著者： Moser M/Hebert P/Hennekens CH

発行年： 1991

Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators//出典: Circulation/ 102巻, 13号, 1503-10頁/ 発行年 2000年

著者： Pitt B/Byington RP/Furberg CD/Hunninghake DB/Mancini GB/Miller ME/Riley W

発行年： 2000

Effects of low-dose angiotensin II receptor blocker candesartan on cardiovascular events in patients with coronary artery disease//出典: Am Heart J/ 146巻, 6号, E20頁/ 発行年 2003年

著者： Kondo J/Sone T/Tsuboi H/Mukawa H/Morishima I/Uesugi M/Kono T/Kosaka T/Yoshida T/Numaguchi Y/Matsui H/Murohara T/Okumura K

発行年： 2003

Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial//出典: Hypertens Res/ 27巻, 3号, 181-91頁/ 発行年 2004年

著者： Yui Y/Sumiyoshi T/Kodama K/Hirayama A/Nonogi H/Kanmatsuse K/Origasa H/Iimura O/Ishii M/Saruta T/Arakawa K/Hosoda S/Kawai C/Japan Multicenter Investigation for Cardiovascular Diseases-B Study Group

発行年： 2004

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators//出典: N Engl J Med/ 335巻, 14号, 1001-9頁/ 発行年 1996年

著者： Sacks FM/Pfeffer MA/Moye LA/Rouleau JL/Rutherford JD/Cole TG/Brown L/Warnica JW/Arnold JM/Wun CC/Davis BR/Braunwald E

発行年： 1996

Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?//出典: Ann Intern Med/ 144巻, 12号, 884-93頁/ 発行年 2006年

著者： Messerli FH/Mancia G/Conti CR/Hewkin AC/Kupfer S/Champion A/Kolloch R/Benetos A/Pepine CJ

発行年： 2006

Effect of antecedent hypertension and follow-up blood pressure on outcomes after high-risk myocardial infarction//出典: Hypertension/ 51巻, 1号, 48-54. Epub 2007 Nov 19頁/ 発行年 2008年

著者： Thune JJ/Signorovitch J/Kober L/Velazquez EJ/McMurray JJ/Califf RM/Maggioni AP/Rouleau JL/Howlett J/Zelenkofske S/Pfeffer MA/Solomon SD

発行年： 2008

How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis//出典: J Hypertens/ 24巻, 11号, 2131-41頁/ 発行年 2006年

著者： Bradley HA/Wiysonge CS/Volmink JA/Mayosi BM/Opie LH